Trial Profile
Kinematic Characterization of Upper Limb Parkinson's Disease Tremor for Optimized Botulinum Toxin Type A Therapy
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Mar 2022
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Parkinson's disease; Tremor
- Focus Therapeutic Use
- 09 Mar 2020 Planned End Date changed from 1 Feb 2021 to 1 Dec 2020.
- 09 Mar 2020 Planned primary completion date changed from 1 Feb 2020 to 1 Aug 2020.
- 24 Apr 2019 Planned primary completion date changed from 1 Feb 2019 to 1 Feb 2020.